Our Products
At CELYSTRA Pharma we strive to bring highly differentiated innovative medicines with strong clinical value propositions to patients who need these the most.
Now available in Canada
Regulations in Canada limit what information can be provided on prescription drugs. The information on this site is intended for residents of Canada only. For more information, please consult with your healthcare provider.
Currently under review by Health Canada
A filing for a secondary indication for Tryngolza
A filing for a treatment of Hereditary Angioedema (HAE)
Partnerships
Accelerating access to patients.
We bring the know-how to effectively navigate partnered medicines through regulatory approval and Canada’s complex market access environment with a focus on commercial availability.